Metabolite News and Research

RSS

Metabolites are the intermediates and products of metabolism. The term ''metabolite'' is usually restricted to small molecules.

Fine-tuning fertility testing with take-home technology

A take-home fertility-testing kit under development in a Massey University laboratory will give women and couples further control over pregnancy planning.

6 Sep 2005

IP 751 a marijuana-derived drug effectively suppresses pain and bladder overactivity in hypersensitive bladder disorders

IP 751, a potent synthetic analog of a metabolite of THC-the principal active ingredient of marijuana-effectively suppresses pain and bladder overactivity in hypersensitive bladder disorders such as interstitial cystitis (IC), according to animal model study results presented today at the annual meeting of the International Continence Society.

1 Sep 2005

Mushrooms are a great source of antioxidants

Using a new, more sensitive-testing approach they developed for fungi, Penn State food scientists have found that mushrooms are a better natural source of the antioxidant ergothioneine than either of the two dietary sources previously believed to be best

31 Aug 2005

Nationwide survey reports a high rate of concern about body image in both boys and girls

A nationwide survey of more than 10,000 adolescents, published in the August issue of Pediatrics, reports a high rate of concern about body image in both boys and girls, and finds that adolescents with such concerns are much more likely to use hormones and dietary supplements to enhance their physique.

1 Aug 2005

Potatoes found to help reduce blood pressure and other diseases

UK scientists have identified bioactive plant chemicals in the most practical of staple foods, the potato. These natural chemicals have been associated with reduced blood pressure and they selectively affect a chemotherapeutic target for trypanosomes and similar diseases such as sleeping sickness.

30 Jun 2005

New drug candidate against HIV-infection

As a part of a research collaboration, scientists at the Sahlgrenska Academy at Gotenborg University, Sweden, have developed a new drug candidate against HIV-infection. The new substance, named alphaHGA, will be tested on patients this year.

30 Jun 2005

New research raises the possibility that the risk of developing arsenic-related disease is not the same for everybody

Children with a particular variation in the CYT19 gene metabolize arsenic differently than adults with the same genetic variant, according to a new research report. The findings have important implications for the safety of drinking water worldwide and the use of arsenic as a cancer drug.

27 Jun 2005

Pregnant women's exposure to phthalates has adverse effects on genital development in their male children

For the first time, researchers have identified an association between pregnant women’s exposure to a nearly ubiquitous class of chemicals known as phthalates and adverse effects on genital development in their male children.

30 May 2005

Brain fatty acid levels linked to depression

A group of researchers from Israel has discovered that rats exhibiting the signs of depression have increased levels of the omega-6 fatty acid, arachidonic acid, in their brains. The details of their findings appear in the June issue of the Journal of Lipid Research, an American Society for Biochemistry and Molecular Biology journal.

25 May 2005

Researchers identify new areas of gene regulation

Researcher Kangling Zhang at the University of California, Riverside is part of a team that has discovered a new way that yeast governs genetic expression and repression, a finding that could be repeated in cells of other organisms.

8 May 2005

Glucose byproduct prevents brain damage after diabetic coma

A natural, non-toxic byproduct of glucose may prevent brain cell death and cognitive impairment in diabetics following an episode of severely low blood sugar, according to researchers at the San Francisco VA Medical Center (SFVAMC).

4 May 2005

Researchers determine mechanism of action of chemotherapy drug motexafin gadolinium

The chemotherapy drug motexafin gadolinium (brand name: Xcytrin, manufactured by Pharmacyclics, Inc.) works to thwart cancer cells by disrupting key enzymes involved in cellular metabolism, according to a team of researchers led by Joseph Hacia, Ph.D., assistant professor of biochemistry and molecular biology at the Keck School of Medicine of the University of Southern California.

1 May 2005

Natural glucose byproduct prevents brain damage and cognitive impairment after diabetic coma

27 Apr 2005

Selenium will have critical role in prostate cancer treatment

Researchers at Fox Chase Cancer Center in Philadelphia have come a step closer to understanding selenium's molecular role in causing prostate cancer cells to self-destruct. According to data presented today at the 96th Annual Meeting of the American Association for Cancer Research in Anaheim, Calif., selenium helps malignant cells overcome their resistance to TRAIL-induced apopstosis (self-inflicted cell death).

20 Apr 2005

Low levels of oral cannabis induces psychosis

Recreational cannabis use has previously been associated with psychotic reactions even in clinical situations where cannabis is administered orally at low doses, now Swiss researcher Dr. Bernard Favrat and colleagues at Institut Universitaire de Medicine Legale in Lausanne have confirmed this in the first such report, in closely monitored subjects participating in a clinical trial.

4 Apr 2005

Cannabis-based medicines given in a highly-controlled clinical environment unexpectedly lead to strong psychotic effects

Volunteers taking cannabis-based therapeutic drugs as part of a controlled trial, which had been approved by an ethics board as safe for the subjects, experienced psychotic effects just as strong as if they had smoked cannabis. These findings, highly unexpected in such a controlled environment, are published today in the peer-reviewed, Open Access journal BMC Psychiatry.

3 Apr 2005

Garlic protects against severe chronic pulmonary hypertension

Small daily doses of allicin, the active metabolic in garlic, proved effective in preventing a severe form of pulmonary hypertension in rats

3 Apr 2005

Docosahexaenoic acid may protect against the accumulation of a protein believed to be linked to Alzheimer's disease

Docosahexaenoic acid (DHA), an omega-3 fatty acid, may protect against the accumulation of a protein believed to be linked to Alzheimer's disease, according to the results of a new study published in the March 30, 2005 issue of The Journal of Neuroscience. The study used Martek DHA, which is produced from microalgae.

23 Mar 2005

Green alga closes wounds by means of enzymatic activation of a cross-linking protein

A small wound is painful, but is normally not a problem. Like all multicellular organisms, our bodies form new tissue around the damaged cells. Single-celled organisms cannot do this. In order to survive an injury, they have to quickly repair the cell itself. Large single-celled organisms, such as the green alga Caulerpa taxifolia, which can be several meters long, are especially at risk for injuries.

22 Mar 2005

Sudden emotional stress can result in severe but reversible heart muscle weakness

Shocking news, such as learning of the unexpected death of a loved one, has been known to cause catastrophic events, such as a heart attack.

10 Feb 2005